Therapeutic Apheresis and Immunosuppression in Renal Diseases
نویسندگان
چکیده
منابع مشابه
Therapeutic apheresis in autoimmune diseases
Systemic autoimmune diseases based on an immune pathogenesis produce autoantibodies and circulating immune complexes, which cause inflammation in the tissues of various organs. In most cases, these diseases have a bad prognosis without treatment. Therapeutic apheresis in combination with immunosuppressive therapies has led to a steady increase in survival rates over the last 35 years. Here we p...
متن کاملTherapeutic Apheresis in Dermatological Diseases
Since the mid-1970s, membrane modules became available and plasma separation techniques have gained importance. Therapeutic apheresis (TA) has been successfully introduced in a variety of autoantibody-mediated diseases. In dermatology, TA is increasingly applied as a support treatment for severe and/or refractory autoimmune bullous diseases. All autoimmune disease are characterized by autoantib...
متن کاملTherapeutic apheresis for renal disorders.
This review summarizes the clinical evidence and practical details for the use of plasmapheresis and other apheresis modalities for each indication in nephrology. Updated information on the molecular biology and immunology of each renal disease is discussed in relation to the rationale for apheresis therapy and its place amid other available treatments. Autoantibody-mediated diseases, such as a...
متن کاملTherapeutic Apheresis
1 apheresis . The advent of sophisticated blood cell separators (Figure 1) has dramatically changed the application of apheresis with increasingly specific blood cells being targeted. This technology is now used in both the donor setting for the collection of blood product and in the therapeutic application for the treatment of many disease processes. The technique of apheresis has been develop...
متن کاملTherapeutic Apheresis in Dyslipidemia
In the last decades, LDL apheresis was introduced as an extracorporeal treatment option for patients with homozygous or severe heterozygous familial hypercholesterolemia. The prognosis of patients suffering from severe dyslipidemia, sometimes combined with elevated lipoprotein (a) levels, and coronary heart disease refractory to diet and lipid-lowering drugs is poor. For such patients, regular ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Research and Reports
سال: 2021
ISSN: 2690-1919
DOI: 10.31579/2690-1919/157